The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
DLC‐1:a Rho GTPase‐activating protein and tumour suppressor
Open accessAbstract
Introduction Expression of DLC family proteins Features of DLC family protein domains Biological functions of DLC‐1 Genetic analysis of DLC‐1 function The DLC family proteins in cancer Conclusions and future directions The deleted in liver cancer 1 (DLC‐1) gene encodes a GTPase activating protein that acts as a negative regulator of the Rho family of small GTPases. Rho proteins transduce signals that influence cell morphology and physiology, and their aberrant up‐regulation is a key factor in the neoplastic process, including metastasis. Since its discovery, compelling evidence has accumulated that demonstrates a role for DLC‐1 as a bona fide tumour suppressor gene in different types of human cancer. Loss of DLC‐1 expression mediated by genetic and epigenetic mechanisms has been associated with the development of many human cancers, and restoration of DLC‐1 expression inhibited the growth of tumour cells in vivo and in vitro. Two closely related genes, DLC‐2 and DLC‐3, may also be tumour suppressors. This review presents the current status of progress in understanding the biological functions of DLC‐1 and its relatives and their roles in neoplasia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RHO GTPASES: Biochemistry and Biology
Jaffe, A. B., & Hall, A. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.020604.150721 · Cited by 3,009
Histone deacetylases and cancer: causes and therapies
Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866
Epigenetic stem cell signature in cancer
Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1941 · Cited by 1,143
Large-scale phosphorylation analysis of mouse liver
Villén, J., Beausoleil, S. A., Gerber, S. A., & Gygi, S. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609836104 · Cited by 730
Structure and lipid transport mechanism of a StAR-related domain
Tsujishita (2000) · Nature Structural Biology · doi:10.1038/75192 · Cited by 535
START: a lipid-binding domain in StAR, HD-ZIP and signalling proteins
Ponting, C. P., & Aravind, L. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01362-6 · Cited by 398
Cited by
Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?
Vigil, D., Cherfils, J., Rossman, K. L., & Der, C. J. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2960 · Cited by 819
Roessler, S., Long, E. L., Budhu, A., Chen, Y., Zhao, X., Ji, J., Walker, R., Jia, H., Ye, Q., Qin, L., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.039 · Cited by 319
Self-citationMutational drivers of cancer cell migration and invasion
Novikov, N. M., Zolotaryova, S. Y., Gautreau, A. M., & Denisov, E. V. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01149-0 · Cited by 302
Rho GTPase signaling in cancer progression and dissemination
Crosas-Molist, E., Samain, R., Kohlhammer, L., Orgaz, J. L., George, S. L., Maiques, O., Barcelo, J., & Sanz-Moreno, V. (2022) · Physiological Reviews · doi:10.1152/physrev.00045.2020 · Cited by 272
Endothelial YAP/TAZ Signaling in Angiogenesis and Tumor Vasculature
Hooglugt, A., van der Stoel, M. M., Boon, R. A., & Huveneers, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.612802 · Cited by 82
Metadata
- Authors
- Durkin, M. E., Yuan, B., Zhou, X., Zimonjic, D. B., Lowy, D. R., Thorgeirsson, S. S., & Popescu, N. C.
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2007-09
- Volume
- 11
- Issue
- 5
- Pages
- 1185-1207
- ISSN
- 1582-1838 (ISSN-L)
- 1582-4934
- OpenAlex
- W2048410884
- Cited by
- 191
- References
- 6
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: DLC‐1:a Rho GTPase‐activating protein and tumour suppressor. https://app.cochat.ai/papers/10.1111/j.1582-4934.2007.00098.x
- The paper
- Durkin, M. E., Yuan, B., Zhou, X., Zimonjic, D. B., Lowy, D. R., Thorgeirsson, S. S., & Popescu, N. C. (2007). DLC‐1:a Rho GTPase‐activating protein and tumour suppressor. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/j.1582-4934.2007.00098.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.